In the non-obese diabetic (NOD) mouse, a model of type 1 diabetes, treatment with h(Gly 2 )GLP-2 once daily for 14 days, increases small intestine length and weight, while also improving jejunal transepithelial resistance compared to treatment with saline
Semaglutide is a GLP-1 receptor agonist, while Tirzepatide is a dual agonist that activates both GLP-1 and GIP receptors, potentially leading to greater weight loss and improved metabolic control
Lifestyle Tips Avoid fizzy drinks and excess alcohol
Some patients discover that their genetic predisposition to gastric sensitivity influences their responsea factor the PlexusDx Precision Peptide Genetic Test can identify, helping providers customize your treatment before side effects become problematic
J Agric Food Chem 61(48):1174411758 Noviello M, Caputi AF, Squeo G, Paradiso VM, Gambacorta G, Caponio F (2022) Vine shoots as a source of trans-resveratrol and -viniferin: a study of 23 Italian varieties